Back to results
US 12,746,248 B2Granted
Compounds and formulations
AssigneePro-Al Medico-Technologies, Inc.
InventorShaker A. Mousa
Life of this patent
Estimating the term…
Abstract
This disclosure presents compositions comprising phosphocreatine and nanoparticles containing triiodothyronine (T3), and to their use in treatment of cardiac conditions, particularly cardiac arrest and acute heart failure, as well as conditions generally relating to hypoxia, such as ischemia and stroke.
Claims11
A composition comprising nanoparticles of T3 and phosphocreatine (PCR) encapsulated or immobilized by a biodegradable polymer.
Dependencies are inferred from the claim text.